Genomics and Infectious Disease: Scientific and ELSI Issues of COVID
Genomics is being used in several distinct ways to understand and address the Covid-19 pandemic. Pathogen genomics investigates the genetics of the virus itself and enables identification and tracking of new variants, while host genomics investigates genomic properties in different individuals that influence infection, severity of illness, and transmission. After a brief review of key terms and current knowledge about COVID genomics an ethics framing will be presented to focus on novel ELSI issues relevant to the current pandemic. The session will prioritize engagement and discussion among the panel members and audience.
Our speakers are Gail Geller, ScD, MHS and Priya Duggal, PhD, both from the Center for Bridging Infectious Disease, Genomics, and Society (BRIDGES) at Johns Hopkins University. The session is moderated by Holly Taylor, PhD, MPH at the National Institutes of Health.
For more information on this topic, please see Ethical, Legal, and Social Implications (ELSI) at the Intersection of Genomics and Infectious Diseases in the ELSIhub Collections series. This literature collection is curated and explained by Collection Editors, Debra Mathews,PhD, MA, Assistant Director for Science Programs at the Berman Institute of Bioethics and Associate Professor of Genetic Medicine at Johns Hopkins University and Sheethal Jose, a PhD Student in Bioethics and Health Policy, also at the Johns Hopkins Berman Institute of Bioethics and the Bloomberg School of Public Health.
Tags
Videos in Series
-
ELSI Friday Forum - The Genomics of PTSD Risk: Scientific and Ethical Perspectives
-
ELSI Friday Forum - Population Descriptors in Genomic Research: Applying the NASEM Recommendations
-
ELSI Friday Forum - Legal and Policy Challenges to Privacy in the Post-Genomic and Post-Dobbs Era
-
ELSI Friday Forum - Value and Values in Payment for Gene Therapies
-
ELSI Friday Forum - Visual Storytelling in ELSI Research
-
ELSI Friday Forum - Indigenizing Genomics and Advancing Indigenous Data Sovereignty
-
ELSI Friday Forum - Wrestling with Social and Behavioral Genomics
-
ELSI Friday Forum - Genetic Advantages in Sports: When Do They Count as "Doping"?
-
ELSI Friday Forum - Genetics and AI: Group Privacy and Fairness
-
ELSI Friday Forum - Advocacy and Allyship in ELSI: Opportunities and Challenges
-
ELSI Friday Forum - Decoloniality and Genetic Ancestry: Situating the "African Genome"
-
ELSI Friday Forum - Legal Challenges to Newborn Screening Research
-
ELSI Friday Forum - Impact of SCOTUS's Dobbs Decision on Prenatal Genomics Research and Practice
-
ELSI Friday Forum - Addressing Algorithmic Harms: Practices and Provocations for Health AI
-
ELSI Friday Forum - Balancing Data Privacy and Data Sharing: Normative and Technical Approaches
-
ELSI Friday Forum - Genomic Imaginaries: Sparking Dialogue between ELSI and Literary Studies
-
ELSI Friday Forum - Ensuring Equitable Use of New Genetic Technologies: Lessons from Eugenics
-
ELSI Friday Forum - New ACMG Guidance on Carrier Screening: More or Less Equitable?
-
ELSI Friday Forum - Benefit-sharing and Pharmaceutical Development in Africa: What Does Equity Mean?
-
ELSI Friday Forum - Genomic Data Sharing: Putting Principles and Policy into Practice
-
ELSI Friday Forum - Current Legal Challenges to Abortion: Implications for Prenatal Genetics
-
ELSI Friday Forum - Ethical Challenges in Novel Gene Therapies for Sickle Cell Disease
-
ELSI Friday Forum - Widening the Lens: Using Arts in ELSI Research
-
ELSI Friday Forum - Migrant DNA: Context, Ethics and Legal Issues
-
ELSI Friday Forum - ELSI Friday Forum: Biobanking in the Era of COVID
-
ELSI Friday Forum - Addressing Racism in Research and Clinical Practice
-
ELSI Friday Forum - ELSI Friday Forum: Structural Racism and Genomics in the Time of COVID